Detalles de la búsqueda
1.
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.
Cell Chem Biol
; 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537632
2.
BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies.
Hum Reprod
; 28(8): 2253-64, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23739217
3.
Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women.
J Med Chem
; 63(20): 11854-11881, 2020 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32960053
4.
Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models.
J Med Chem
; 63(13): 7293-7325, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502336
5.
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo.
Clin Cancer Res
; 25(4): 1404-1414, 2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429199
6.
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies.
ChemMedChem
; 13(21): 2271-2280, 2018 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407750
7.
The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study.
Reprod Biol Endocrinol
; 5: 1, 2007 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-17241468
8.
10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception.
J Androl
; 28(3): 362-3, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17192594
Resultados
1 -
8
de 8
1
Próxima >
>>